A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study

SIMPLE SUMMARY: Systemic therapies for advanced biliarty tract cancers (BTC) are limited. The combination of gemcitabine with cisplatin (GC) has been the standard first-line treatment for advanced BTC from 2010 until now. In order to improve therapeutic effect, especially response rate, we added a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Sung-Nan, Liao, Chun-Kai, Chen, Yaw-Sen, Tseng, Cheng-Hao, Hung, Chao-Ming, Chiu, Chong-Chi, Hsieh, Meng-Che, Tsai, Yu-Fen, Liao, Hsiu-Yun, Liu, Wei-Ching, Rau, Kun-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345065/
https://www.ncbi.nlm.nih.gov/pubmed/34359732
http://dx.doi.org/10.3390/cancers13153831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345065/
https://www.ncbi.nlm.nih.gov/pubmed/34359732
http://dx.doi.org/10.3390/cancers13153831

Ejemplares similares